You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,688,047


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,688,047 protect, and when does it expire?

Patent 10,688,047 protects DUVYZAT and is included in one NDA.

This patent has thirty-five patent family members in twenty-nine countries.

Summary for Patent: 10,688,047
Patent landscape, scope, and claims:
Title:Physically and chemically stable oral suspensions of givinostat
Abstract:Physically and chemically stable oral liquid formulations of Givinostat (Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride) are disclosed, together with methods for the preparation thereof. Such oral formulations are in the form of aqueous suspensions and contain Givinostat and/or pharmaceutically acceptable salts and/or derivatives thereof, at least a wetting agent and/or at least a density-imparting agent. Such formulations are suitable for oral administration for systemic therapeutic action.
Inventor(s):Colombo Giuseppe, Artico Roberta, Mascagni Paolo, Monzani Maria Valmen, Puccianti Silvia
Assignee:ITALFARMACO SPA
Application Number:US15770443
Patent Claim Types:
see list of patent claims
 

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,688,047

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Italfarmaco Spa DUVYZAT givinostat hydrochloride SUSPENSION;ORAL 217865-001 Mar 21, 2024 RX Yes Yes 10,688,047 ⤷  Subscribe Y A METHOD FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY (DMD) USING GIVINOSTAT ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,688,047

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 106559 ⤷  Subscribe
Australia 2016349169 ⤷  Subscribe
Brazil 112018008870 ⤷  Subscribe
Brazil 122024001653 ⤷  Subscribe
Canada 3002755 ⤷  Subscribe
Chile 2018001151 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.